The gains were modest but meaningful. One patient improved by two stages on the Hoehn–Yahr scale, a widely used measure of Parkinson's severity. Another saw a 50% improvement in motor function during off-medication testing.
"It is a significant achievement that we have been able to confirm improvement in patients' symptoms," said Jun Takahashi, director of Kyoto University's Center for iPS Cell Research and Application, who is leading the research. "We hope to deliver this treatment to patients as soon as possible."
"It is a significant achievement that we have been able to confirm improvement in patients' symptoms," said Jun Takahashi, director of Kyoto University's Center for iPS Cell Research and Application, who is leading the research. "We hope to deliver this treatment to patients as soon as possible."
No comments:
Post a Comment